Literature DB >> 18220750

Adhesion molecules and kinases involved in gammadelta T cells migratory pathways: implications for viral and autoimmune diseases.

Alessandro Poggi1, Silvia Catellani, Daniela Fenoglio, Giovanna Borsellino, Luca Battistini, Maria Raffaella Zocchi.   

Abstract

gammadelta T lymphocytes are involved in the defence from viral and mycobacterial infections; however they are also responsible for autoimmune reactions. Herein, we discuss the characteristics of these cells, focusing on the mechanism(s) underlying extravasation and tissue localization. We show that Vdelta1 and Vdelta2 gammadeltaT cells display differential expression of adhesion molecules and chemokine receptors, the former being preferentially PECAM-1(+)CXCR4(+), the latter expressing NKRP1A and CXCR3. The two cell populations transmigrate across endothelial cells by activation of distinct kinase pathways and in response to interferon-gamma-inducing protein-10 (IP-10/CXCL10) or stromal-derived factor-1 (SDF-1/CXCL12) according to the expression of the specific receptors CXCR3 and CXCR4. IP-10/CXCL10 and SDF-1/CXCL12-induced transmigration are phosphoinositide-3 kinase (PI-3K) and Akt/PKB-dependent. In addition, occupancy of CXCR3, but not of CXCR4, leads to CAMKII activation; blocking of CAMKII decreases IP-10/CXCL10 and 6Ckine/SLC/CCL21-driven transmigration. We report that HIV-1-infected patients have an increased number of circulating Vdelta1 T cells possibly due to the interference of Tat protein on the function of chemokine receptors. In turn, patients with relapsing-remitting multiple sclerosis (MS), display an increase in peripheral Vdelta2 gammadelta T cells and this is related to interleukin-12-mediated upregulation of NKRP1A. Finally, the possible role of gammadelta T lymphocytes in post-transplantation immune reconstitution is discussed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18220750     DOI: 10.2174/092986707782793835

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  6 in total

1.  Identification of a novel immunomodulatory gliadin peptide that causes interleukin-8 release in a chemokine receptor CXCR3-dependent manner only in patients with coeliac disease.

Authors:  Karen M Lammers; Sunaina Khandelwal; Fatima Chaudhry; Debby Kryszak; Elaine L Puppa; Vincenzo Casolaro; Alessio Fasano
Journal:  Immunology       Date:  2010-11-23       Impact factor: 7.397

2.  Naturally presented peptides on major histocompatibility complex I and II molecules eluted from central nervous system of multiple sclerosis patients.

Authors:  Nicolas Fissolo; Sabrina Haag; Katrien L de Graaf; Oliver Drews; Stefan Stevanovic; Hans Georg Rammensee; Robert Weissert
Journal:  Mol Cell Proteomics       Date:  2009-06-16       Impact factor: 5.911

3.  The SDF-1 3'a genetic variation of the chemokine SDF-1α (CXCL12) in parallel with its increased circulating levels is associated with susceptibility to MS: a study on Iranian multiple sclerosis patients.

Authors:  Hossein Azin; Reza Vazirinejad; Behzad Nasiri Ahmadabadi; Hossein Khorramdelazad; Ebrahim Rezazadeh Zarandi; Mohammad Kazemi Arababadi; Mojgan Noroozi Karimabad; Ali Shamsizadeh; Houshang Rafatpanah; Gholamhossein Hassanshahi
Journal:  J Mol Neurosci       Date:  2011-11-29       Impact factor: 3.444

4.  γδ T cells enhance autoimmunity by restraining regulatory T cell responses via an interleukin-23-dependent mechanism.

Authors:  Franziska Petermann; Veit Rothhammer; Malte C Claussen; Jan D Haas; Lorena Riol Blanco; Sylvia Heink; Immo Prinz; Bernhard Hemmer; Vijay K Kuchroo; Mohamed Oukka; Thomas Korn
Journal:  Immunity       Date:  2010-09-09       Impact factor: 31.745

5.  Peripheral viral challenge increases c-fos level in cerebral neurons.

Authors:  Tiffany J Petrisko; Gregory W Konat
Journal:  Metab Brain Dis       Date:  2021-08-18       Impact factor: 3.584

6.  Inhibition of gluconeogenesis in primary hepatocytes by stromal cell-derived factor-1 (SDF-1) through a c-Src/Akt-dependent signaling pathway.

Authors:  Hui-Yu Liu; Ge-Bo Wen; Jianmin Han; Tao Hong; Degen Zhuo; Zhenqi Liu; Wenhong Cao
Journal:  J Biol Chem       Date:  2008-09-11       Impact factor: 5.157

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.